메뉴 건너뛰기




Volumn 53, Issue 5, 2003, Pages 321-329

In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations

Author keywords

CAS 54 31 9; Furosemide CINFA ; Furosemide, bioavailability, bioequivalence, in vitro and in vivo studies, pharmacodynamics, pharmacokinetics

Indexed keywords

CHLORIDE; DIURETIC AGENT; FUROSEMIDE; POTASSIUM; SODIUM;

EID: 0037613382     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297116     Document Type: Article
Times cited : (3)

References (25)
  • 1
    • 0019986952 scopus 로고
    • Pharmaceutical and biological availability of commercial preparations of furosemide
    • Stüber, A., Mutschler, E., Steinbach, D., Pharmaceutical and biological availability of commercial preparations of furosemide. Arzneim.-Forsch./Drug Res. 32 (I), 693 (1982)
    • (1982) Arzneim.-Forsch./Drug Res. , vol.32 , Issue.1 , pp. 693
    • Stüber, A.1    Mutschler, E.2    Steinbach, D.3
  • 2
    • 0020583238 scopus 로고
    • Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers
    • Ogata, H., Zugarni, S., Ejima, A. et al., Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers. Eur. J. Clin. Pharmacol. 24, 791 (1983)
    • (1983) Eur. J. Clin. Pharmacol. , vol.24 , pp. 791
    • Ogata, H.1    Zugarni, S.2    Ejima, A.3
  • 3
    • 0021243165 scopus 로고
    • Comparative bioavailability of two furosemide formulations in humans
    • Martin, B. K., Uihlein, M., Ings, R. M. J. et al., Comparative bioavailability of two furosemide formulations in humans. J. Pharm. Sci. 73, 437 (1984)
    • (1984) J. Pharm. Sci. , vol.73 , pp. 437
    • Martin, B.K.1    Uihlein, M.2    Ings, R.M.J.3
  • 4
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon, G. L., Lenneräs, H., Shah, V. P. et al., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413 (1995)
    • (1995) Pharm. Res. , vol.12 , pp. 413
    • Amidon, G.L.1    Lenneräs, H.2    Shah, V.P.3
  • 5
    • 0031704891 scopus 로고    scopus 로고
    • Assesment of pharmaceutical quality of furosemide tablets from multinational markets
    • Qureshi, S. A., McGilveray, I. J., Assesment of pharmaceutical quality of furosemide tablets from multinational markets. Drug Dev. Ind. Pharm. 24, 995 (1998)
    • (1998) Drug Dev. Ind. Pharm. , vol.24 , pp. 995
    • Qureshi, S.A.1    McGilveray, I.J.2
  • 6
    • 0038475169 scopus 로고    scopus 로고
    • National Formulary 19 The United States Pharmacopeial Convention Inc., Rockville, MD
    • United States Pharmacopeia 24, National Formulary 19 The United States Pharmacopeial Convention Inc., Rockville, MD (2000)
    • (2000) United States Pharmacopeia , vol.24
  • 7
    • 2342652446 scopus 로고    scopus 로고
    • Mathematical comparison of dissolution profiles
    • Moore, J. W., Flanner, H. H., Mathematical comparison of dissolution profiles. Pharm. Technol. 20, 64 (1996)
    • (1996) Pharm. Technol. , vol.20 , pp. 64
    • Moore, J.W.1    Flanner, H.H.2
  • 8
    • 0003419264 scopus 로고    scopus 로고
    • The European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit (CPMP/EWP/QWP/1401/98/Draft)
    • CPMP (Committee for Propietary Medicinal Products). Note for Guidance on the Investigation of Bioavailability and Bioequivalence. Draft document. The European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit (CPMP/EWP/QWP/1401/98/Draft) (1998)
    • (1998) Note for Guidance on the Investigation of Bioavailability and Bioequivalence. Draft Document
  • 9
    • 0029128554 scopus 로고
    • Reference tables for the intrasubject coefficient of variation in bioequivalence studies
    • Steinijans, V. W., Sauter, R., Hauschke, D. et al., Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int. J. Clin. Pharmacol. Ther. 33, 427 (1995)
    • (1995) Int. J. Clin. Pharmacol. Ther. , vol.33 , pp. 427
    • Steinijans, V.W.1    Sauter, R.2    Hauschke, D.3
  • 10
    • 0034469255 scopus 로고    scopus 로고
    • Bioanalytical method validation. A revisit with a decade of progress
    • Workshop/Conference Report
    • Shah, V. P., Midha, K. K., Findlay, J. W. A. et al., Bioanalytical method validation. A revisit with a decade of progress. Workshop/Conference Report. Pharm. Res. 17, 1551 (2000)
    • (2000) Pharm. Res. , vol.17 , pp. 1551
    • Shah, V.P.1    Midha, K.K.2    Findlay, J.W.A.3
  • 13
    • 0023615056 scopus 로고
    • A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
    • Schuirmann, D. J., A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 15, 657 (1987)
    • (1987) J. Pharmacokin. Biopharm. , vol.15 , pp. 657
    • Schuirmann, D.J.1
  • 14
    • 0026832969 scopus 로고
    • On the assesment of bioequivalence in a two-period crossover design
    • Wijnand, H. P., On the assesment of bioequivalence in a two-period crossover design. Comput. Methods Programs Biomed. 37, 151 (1992)
    • (1992) Comput. Methods Programs Biomed. , vol.37 , pp. 151
    • Wijnand, H.P.1
  • 15
    • 0020662337 scopus 로고
    • Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals
    • Steinijans, V. W., Diletti, E., Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur. J. Clin. Pharmacol. 24, 127 (1983)
    • (1983) Eur. J. Clin. Pharmacol. , vol.24 , pp. 127
    • Steinijans, V.W.1    Diletti, E.2
  • 16
    • 0021924569 scopus 로고
    • Generalization of distribution-flee confidence intervals for bioavailability ratios
    • Steinijans, V. W., Diletti, E., Generalization of distribution-flee confidence intervals for bioavailability ratios. Eur. J. Clin. Pharmacol. 28, 85 (1985)
    • (1985) Eur. J. Clin. Pharmacol. , vol.28 , pp. 85
    • Steinijans, V.W.1    Diletti, E.2
  • 19
    • 0023874321 scopus 로고    scopus 로고
    • Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men
    • Waller, E. S., Crismon, M. L., Smith, R. V. et al., Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men. Biopharm. Drug Dispos. 9, 211 (1998)
    • (1998) Biopharm. Drug Dispos. , vol.9 , pp. 211
    • Waller, E.S.1    Crismon, M.L.2    Smith, R.V.3
  • 20
    • 0021714621 scopus 로고
    • Implications of intraindividual variability in bioavailability studies of furosemide
    • Grahnen, A., Hammarlund, M., Lundqvist, T., Implications of intraindividual variability in bioavailability studies of furosemide. Eur. J. Clin. Pharmacol. 27, 595 (1984)
    • (1984) Eur. J. Clin. Pharmacol. , vol.27 , pp. 595
    • Grahnen, A.1    Hammarlund, M.2    Lundqvist, T.3
  • 23
    • 0030748837 scopus 로고    scopus 로고
    • Comparative bioavailability of two atenolol tablets formulations in healthy male volunteers after a single dose administration
    • Martins, M. L., Pierossi, M. A., Moraes, L. A. et al., Comparative bioavailability of two atenolol tablets formulations in healthy male volunteers after a single dose administration. Int. J. Clin. Pharmacol. Ther. 35, 324 (1997)
    • (1997) Int. J. Clin. Pharmacol. Ther. , vol.35 , pp. 324
    • Martins, M.L.1    Pierossi, M.A.2    Moraes, L.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.